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Abstract There is consensus that intracranial dural arterio-
venous fistulae (dAVF) with direct (non-sinus-type) or
indirect (sinus-type) retrograde filling of a leptomeningeal
vein should be treated due to the high risk of neurological
deficits and hemorrhage. No consensus exists on treatment
modality (surgery and/or embolization) and, if surgery is
performed, on the best surgical strategy. This series aims to
evaluate the role of surgery in the management of
aggressive dAVFs. Forty-two patients underwent surgery.
Opening and packing the sinus with thrombogenic material
was performed in 9 of the 12 sinus-type dAVFs. In two
sinus-type fistulae of the cavernous sinus and 1 of the
torcular, microsurgery was used as prerequisite for subse-
quent embolization by providing access to the sinus. In the
30 non-sinus-type dAVFs, surgery consisted of interruption
of the draining vein at the intradural entry point. In 41
patients undergoing 43 operations, elimination of the dAVF
was achieved (97.6%). In one case, a minimal venous
drainage persisted after surgery. The transient surgical
morbidity was 11.9% (n=5) and the permanent surgical
morbidity 7.1% (n=3). Our surgical strategy was to focus
on the arterialized leptomeningeal vein in the non-sinus-
type and on the arterialized sinus segment in the sinus-type
dAVFs allowing us to obliterate all but one dAVF with a
low morbidity rate. We therefore propose that microsurgery
should be considered early in the treatment of both types of
aggressive dAVFs. In selected cases of cavernous sinus
dAVFs, the role of microsurgery is reduced to that of an
adjunct to endovascular therapy.
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Introduction
The aggressive type of intracranial dural arteriovenous
fistulae (dAVF) with either direct (non-sinus-type dAVF)
or indirect (sinus-type dAVF) retrograde filling of a
leptomeningeal vein has a high propensity of ischemia,
intracranial hypertension, and cerebral bleeding [8, 44]. If
left untreated, the mortality rate is 10.4%, the annual
bleeding and the nonhemorrhagic neurological deficit risks
are 8.1% and 6.9%, respectively. This leads to an annual
event-rate of 15% [44]. Even benign dAVFs bear a risk of
2% to develop cortico-venous reflux with a subsequent
risk of complications [33].
Therefore, consensus exists, that aggressive-type dAVFs
should be treated [2–4, 6, 8, 10, 17, 22, 24, 46]. However,
dAVFs are rare vascular lesions and large institutional
series published so far are seldom [8, 18]. This explains
why no clear consensus exists on treatment modality
(surgery and/or embolization) and, if surgery is performed,
on the best surgical strategy [7, 8, 12, 16, 18, 22, 23, 26,
28, 32–35, 37, 40, 44, 46, 48]. After having treated 42
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Materials and methods
Study design
We retrospectively reviewed the medical records of patients
with surgically managed dAVFs between 1990 and 2010
either at the department of neurosurgery at the University of
Göttingen (2005–2010) or the University of Technology
Aachen (1990–2004). The series is a consecutive surgical,
but not un-biased series, because in five patients with sinus-
type fistulae and four patients with non-sinus-type fistulae
embolization was initially attempted without success.
Patients
There were 42 patients (33 male, 9 female, median age of
58.4 years) with angiographically proven dAVFs (Table 1).
Sinus fistulae (Fig. 1a and b) were found in 12 cases. The
fistulae were located on the sigmoid/transverse sinus (n=6),
the superior sagittal sinus (n=1), straight sinus (n=1),
cavernous sinus (n=3), and superior petrous sinus (n=1).
There were 30 patients with non-sinus-type fistulae
(Fig. 2a, b and c), with pure drainage into arterialized
cortical veins, which were found at the convexity (n=7),
temporal (n=3), posterior fossa/foramen magnum (n=4),
anterior fossa (n=7) and tentorial (n=9) as subsumed in
Table 1. According to the angiographic criteria, 12 fistulae
had been classified Borden type 2 and 30 fistulae Borden
type 3 [4] according to the Borden Classification as
described in Table 2.
Clinical findings
Clinical findings were epileptic seizures, pareses, aphasia or
dysphasia, visual deficits, headache, gait disturbances,
tinnitus, loss of consciousness, vertigo, dysmetria, apraxia,
bulbous protrusion, and chemosis in 9 (21.4%), 7 (16.7%),
7 (16.7%), 5 (9, 11), 6 (14.3%), 5 (11.9%), 3 (7.1%), 3
(7.1%), 2 (4.8%), 2 (4.8%), 2 (4.8%), 2(4.8%) and 1(2.4%)
cases, respectively (Table 3). Sixteen patients (40.5%)
suffered from intracerebral or subarachnoid hemorrhage.
Multiple findings occurred in 12 patients (28.6%). Fistulae
were discovered incidentally in three asymptomatic patients
(7.1%)
Table 1 Patient collective
Average age Years 58.4
Min age Years 35
Max age Years 72
Gender (N)
Female 9 21.4%
Male 33 78.6%
Sinus fistula (n) 12 [28.6%]
Sigmoid/transverse sinus 6 14.3%
Superior sagittal sinus 1 2.4%
Straight sinus 1 2.4%
Cavernous sinus 3 7.1%
Superior petrous sinus 1 2.4%
Non-sinus-fistula (n) 30 [71.4%]
Convexity 7 16.7%
Tentorial 9 19.5%
Anterior fossa 7 16.7%
Posterior fossa/for. magnum 4 9.5%
Temporal 3 7.1%
Fig. 1 a Preoperative angiographic finding of a sinus-type (sigmoid
sinus) fistula. b Postoperative angiography demonstrating complete
fistula occlusion after microsurgical sinus packing
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In the non-sinus-type fistulae, the operative strategy
consisted of sole interruption of the arterialized leptome-
ningeal vein, shortly after the dural entry/exit point, either
by coagulation and cutting (n=22) or by clipping (n=8). No
attempt was made to coagulate the feeding meningeal
arteries or to excise the arterialized dura. In nine sinus-type
fistulae with easily accessible sinus (transverse, sigmoid,
superior sagittal sinus), the operative strategy consisted of
exposure of the arterialized sinus segment, which then was
packed with oxidized cellulose. No attempt was made to cut
out the arterialized sinus segment in the last nine cases. In
three sinus-type fistulae (one cavernous type and one
straight sinus-type fistulae), the operative strategy was to
provide access to the venous system for retrograde
catheterization and embolization (Table 4). After surgery,
angiography was performed in all patients either immedi-
ately after the operation or after recovery.
Follow-up investigations
If postoperative angiography proved complete dAVF
occlusion, patients were re-investigated yearly for at least
3 years clinically and radiologically using MRI and/or CT
angiography and/or angiographic CT. In the absence of
abnormal feeding arteries and/or arterialized draining veins
and sinus segments, and stable or improving clinical status,
no repeated angiography was performed. The follow-up
time was 8 weeks to 10 years, with a mean of 4.2 years.
Results
In 39 cases (92.9%), a total elimination of arteriovenous
shunting could be achieved by the initial operation. In an
extensive torcular/straight sinus and one ethmoidal dAVF,
two operations were necessary for complete fistula occlu-
sion. In two cases of sinus cavernous dAVFs, retrograde
Fig. 2 a Preoperative
angiographic finding of a
non-sinus-type (temporal) fistula
b: Three-dimensional
reconstruction of CT angiogra-
phy showing a non-sinus-type
fistula: the images are
suggestive of an occipital fistula
with ectasies of arterialized
leptomeningeal vein. Intraoper-
atively, those ectasies were
found to be completely within
the dural layers with the origin
of the leptomeningeal vein in
the anterior temporal fossa.
c Postoperative angiography
proving complete occlusion of
the fistula following temporo-
dorsal trephination and coagula-
tion of the leptomeningeal vein
Borden Type I dAVF drainage into a dural venous sinus or meningeal vein with anterograde flow
Borden Type II Anterograde drainage into dural venous sinus, retrograde flow occurs into cortical veins
Borden Type III Direct retrograde flow of blood from the fistula into cortical veins
Table 2 The Borden classifica-
tion system
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way obliterated the fistula: in one patient, the superior
ophthalmic vein was exposed microsurgically, in another
patient, the initially inaccessible petrous sinus was opened
by disconnecting the arterial outflow and, thereby, increas-
ing the intracavernous pressure. In the third patient, with a
cavernous sinus fistula, retrograde venous embolization via
the petrous sinus and via the superior ophthalmic vein
failed, and microsurgical cavernous sinus packing was
successfully performed. In one case of a tentorial dAVF, a
minimal venous drainage persisted after surgery. In total,
the dAVF occlusion rate was 97.6% (Table 4).
Intra- and postoperative complications
Permanent, surgery-associated, neurological deficits were
found in 3 (7.1%) out of 42 patients (hyposmia, hemi-
anopsia, and dysmetria in one case each). Transient
morbidity occurred in five (11.9%) patients. Pneumatoce-
phalus in one patient and rebleeding in one patient required
a second intervention without permanent neurological
deficits. The rebleeding occurred in the only case of
sinus-type fistulae, in which the arterialized sinus segment
was resected. Cerebrospinal fluid (CSF) leakage developed
in one patient, which was successfully managed by lumbar
CSF drainage. In one case each, a transient paresis of the
abducens or oculomotor nerve developed.
Follow-up investigations and outcome
After a mean follow-up period of 4.2 years, no re-opening
of the initially occluded fistula, as indicated by the absence
of arterialized cortical veins and/or sinus segments on MRI
and/or CT, was seen. The minimal venous drainage after
incomplete occlusion of a tentorial fistula, which was
repeatedly followed by angiographies, remained unchanged
during the follow-up period and was not re-treated so far.
Fifteen of 16 patients, who experienced a subarachnoid or
intracerebral hemorrhage, experienced incomplete recovery.
Eight patients (19.0%) with symptoms related to venous
congestion showed an improvement of one or more
preoperative clinical symptoms. Tinnitus and headache
improved in two patients each (4.8%). Five patients
(11.9%) were seizure-free after surgery.
Discussion
Dural arteriovenous fistulae are rarer than other intracranial
vascular malformations. The development of dAVFs after
sinus thrombosis, operation, and trauma involving the sinus
had been described. Furthermore, animal experiments
indicate that venous hypertension could induce dAVFs
possibly mediated by vascular endothelial growth factor
[14, 21, 34, 39]. Thus, it is assumed by many that dAVFs
are acquired lesions [7].
In 1990, Awad et al. performed a meta-analysis of 377
patients with cranial dAVFs previously presented in the
medical literature. They concluded that the pattern of
venous drainage is the primary determinant of aggressive
behavior [2]. If the flow-through dAVFs empties into
leptomeningeal veins either directly or via an arterialized
sinus, it can cause venous tortuosity, variceal dilatation of
pial veins, and local or regional intraparenchymal venous
congestion which has a high propensity to result in
nonhemorrhagic neurological deterioration, ischemia, intra-
cranial hypertension, or cerebral bleeding [40]. Patients
with aggressive dAVFs have an annual event-rate of 15%
[44]. These data are confirmed by Singh et al. who
analyzed 73 patients with intracranial bleeding out of 402
patients with dAVFs. They concluded that the bleeding risk,
among others, rises with cortical venous drainage [35].
Independently from each other, Borden et al. and Cognard
et al. proposed a classification of dAVFs based on the
angiographic characteristics of non-aggressive and aggres-
sive fistulae in 1995 [4, 7].
Consensus exists, that aggressive dAVFs should be
treated to reduce the risk of bleeding and neurological
deficits, but there is an ongoing discussion if microsur-
gery or endovascular obliteration or a combination of
both offers the chance to eliminate the arterial flow in the
leptomeningeal-draining vein. The rarity of dAVFs per
se, the different angioarchitecture of sinus-type and non-
sinus-type fistulae and the different fistula sites explain
why no studies exist which compared microsurgery with
endovascular therapy.
Table 3 Neurological findings
Presenting symptoms [%]
Intracranial hemorrhage/SAH 16 38.1
Seizure 9 21.4
Pareses 7 16.7
Aphasia or dysphasia 7 16.7
Visual deficits 6 14.3
Headache 6 14.3
Gait disturbances 5 11.9
Tinnitus 3 7.1
Loss of consciousness 3 7.1
Vertigo 2 4.8
Dysmetria 2 4.8
Apraxia 2 4.8
Bulbous protrusion 2 4.8
Chemosis 1 2.4
Incidental 3 7.1
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Patient no. Type Location Approach Treatment Endovascular Outcome angio
1 ST SS/TS RS Packing with OS CO
2 ST SS/TS RS Packing with OS CO
3 ST SS/TS RS Packing with OS CO
4 ST SS/TS RS Packing with OS CO
5 ST SS/TS SO Packing with M E transvenous CO
6 ST SS/TS SO Sinus Resection E transvenous CO
7 ST SSS OC/SO Packing with OS CO
8 ST CS Pterional Cautery/division E transvenous po CO
9 ST CS Pterional RCEaC E transvenous po CO
10 ST CS Pterional Packing with OS CO
11 ST SPS OC/SO Packing with OS CO
12 ST STRS Parietal + SO 1. Packing with OS E transvenous po CO
2. RCEaC
13 NST Convexity Parietal Clip ligation CO
14 NST Convexity Parietal Cautery/division CO
15 NST Convexity Parietal Cautery/division CO
16 NST Convexity Parietal Cautery/division CO
17 NST Convexity Temporal Cautery/division CO
18 NST Convexity OC Clip ligation CO
19 NST Convexity Parieto-OC Cautery/division CO
20 NST Anterior fossa IH Clip ligation CO
21 NST Anterior fossa IH Cautery/division CO
22 NST Anterior fossa IH Cautery/division CO
23 NST Anterior fossa IH Cautery/division CO
24 NST Anterior fossa IH Cautery/division CO
25 NST Anterior fossa Frontobasal Cautery/division CO
26 NST Anterior fossa Frontobasal Cautery/division CO
27 NST Tentorial S/I Cautery/division E arterial preop CO
28 NST Tentorial SO Cautery/division Residual
29 NST Tentorial SO Clip ligation CO
30 NST Tentorial RM Clip ligation CO
31 NST Tentorial Subtemporal Cautery/division E arterial preop CO
32 NST Tentorial OC/SO Cautery/division CO
33 NST Tentorial RM Clip ligation CO
34 NST Tentorial SO Cautery/division CO
35 NST Tentorial SO Cautery/division E arterial preop CO
36 NST PF/FM RM Cautery/division CO
37 NST PF/FM FME Clip ligation CO
38 NST PF/FM FME Cautery/division CO
39 NST PF/FM SO Cautery/division CO
40 NST Temporal AS Cautery/division E arterial preop CO
41 NST Temporal Subtemporal Clip ligation CO
42 NST Temporal Temporal Cautery/division CO
SS/TS sigmoid/transverse sinus, SSS superior sagittal sinus, STRS straight sinus, CS cavernous sinus, SPS superior petrous sinus, PF/FM posterior
fossa/foramen magnum, RM retromastoid approach, SO suboccipital paramedian/median approach, OC occipital approach, IH interhemispheric
approach, S/I supracerebellar/infratentorial, FME foramen magnum enlargement, AS anterosigmoid approach, OS oxidized cellulose, M muscle,
po postoperative, E embolization, RCEaC retrograde coil-embolization after craniotomy
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In non-sinus-type fistule, the institutional strategy was to
interrupt the arterialized leptomeningeal vein, shortly after
the dural entry/exit point without attacking the meningeal
feeding arteries or excising the arterialized dura. Because
these draining veins have inverted flow, the occlusion at
their dural origin is not followed by further venous
congestion [8, 16, 22, 40, 43, 45]. After occlusion, the
draining vein thromboses without significant hemodynam-
ical changes due to downstream veins that already have
resumed the draining of functional cerebral areas. We
achieved an overall occlusion rate of non-sinus-type fistulae
in 97.6%. The permanent surgery-associated morbidity rate
for the whole series was 7.1%, and for the non-sinus-type
fistulae 4.8% (n=2). The induced neurological deficits
could be considered to be minor. Neuronavigation, using
CT angiographic data, proved to be helpful for intra-
operative identification of the first segment of the
leptomeningeal-draining vein [18]. An increasing number
of publications support this concept and report comparable
occlusion and morbidity rates [8, 16, 18, 22, 40].
Experiences with the endovascular management of non-
sinus-type dAVFs likewise have been reported, but in many
series the occlusion rate is lower and the complication rate
higher [46]. With transarterial embolization, using particles
or N-butyl-2-cyanoacrylate occlusion rates between 28%
and 33% could be achieved [40, 43]. Better results were
obtained by Agid et al., who achieved angiographic cure in
63.6% [1]. First experiences indicate that transarterial
embolization with Onyx has the potential to yield higher
occlusion rates. Jiang et al. report an occlusion rate of
68.4% [47]. In the series of Carlson et al. and Nogueira et
al., the occlusion rate was even higher with 80% and 83%,
respectively [5, 28]. Exceptionally good results were
reported by Rossitti, who achieved a 100% occlusion rate
[31]. Retrograde transvenous routes are rarely used in non-
sinus-type fistulas due to the assumable high risk of rupture
of the already fragile leptomeningeal-draining vein [9, 26,
44]. Some combined transarterial and transvenous techni-
ques. In a very recent paper, an occlusion rate of 96% had
been reported in 25 patients [19]. However, it remained
unclear if true non-sinus-type fistulas were treated in this
series because an involvement of the sinus was described
for all cases. Complication rates of 9%, occasionally of up
to 21%, and even fatalities have been reported in
contemporary endovascular series [19, 41, 45, 46, 48]. In
consequence, we propose that microsurgical interruption of
the draining vein should be the treatment of first choice in
all patients with non-sinus-type dAVFs. This especially
holds true because the leptomeningeal-draining vein is
easily accessible by standard neurosurgical approaches in
most instances [25]. The very recent papers of Rossitti and
Kirsch et al. indicate that advanced endovascular techni-
ques yield results which are comparable to surgical results.
Possibly, our proposal has to be re-evaluated with further
up-coming endovascular series. Arterial embolization to
m i t i g a t eb l o o dl o s sd u r i n gs u r g e r yi sp r o p o s e db ys o m e
[18, 30]. However, in non-sinus-type fistulae we never
experienced brisk bleeding during coagulation or clipping
of the leptomeningeal vein, and therefore question the
usefulness of preoperative arterial embolization.
Sinus-type fistulae
In sinus-type fistulae of sinuses, which are easily accessible
by surgery (sigmoid/transverse sinus, superior sagittal
sinus), our institutional strategy was to expose the arterial-
ized segment of the sinus, to incise the wall minimally and
to pack the sinus with oxidized cellulose until cessation of
arterial blood flow. We achieved an overall occlusion rate
of 100%, without major morbidity and mortality, and a
minor morbidity rate of 10%. These results are in line with
the few other surgical series [10, 17]. In these surgical
series, sinus packing was achieved with microcoils after
sinus puncture. If sinus packing with coils is more
advantageous than minimal sinus wall incision and packing
with oxidized cellulose will remain a matter of discussion
[17]. Possible arguments against sinus packing with coils
are the higher costs and the need for intraoperative
angiography or patient transfer [29, 30]. In the authors’
opinion, there is rarely the need for microsurgical excision
of the diseased sinus segment for control of the dAVF [3, 8,
30]. Furthermore, excision of the arterialized sinus could
lead to complications as reported in the literature and
witnessed in one case of our series [38]. Van Dijk et al.,
who only disconnected the cortical venous reflux from the
arterialized sinus, proposed a new surgical concept [44].
However, taken the assumed pathophysiology of sinus-type
dAVFs, recruitment of new leptomeningeal veins seems
possible [14, 39]. Furthermore, the assumption of van Dijk
and co-workers that intradural disconnection of the arte-
rialized cortical vein is less risky than sinus packing, which
represents a completely extradural operation, could be
challenged. In sinus-type fistulae, the retrograde trans-
venous embolization yields results, which are comparable
to surgical sinus packing, with an obliteration rate of 81%
to 87.5%, and a permanent morbidity rate of 4% [19, 32].
Transarterial embolization with particles or glue often
yields poorer results. Recently, transarterial embolization
using Onyx has been proposed for the management of
sinus-type fistulae [36]. The reported occlusion rate was
78%. Another endovascular option is conversion of an
aggressive into a non-aggressive fistula type by recanaliza-
tion of the thrombosed sinus, but only single cases have
been reported so far [13, 27]. The comparable results of
342 Neurosurg Rev (2011) 34:337–345microsurgery and retrograde transvenous embolization do
not allow the definition of the superior therapeutic option,
but the lower invasiveness favors transvenous embolization
as the first treatment option. However, microsurgery should
be considered early if transvenous embolization fails.
Cavernous sinus dural arteriovenous fistulae
The cavernous sinus is not easily accessible by microsur-
gery and sinus packing is not without risk for the cranial
nerves [42]. Furthermore, cavernous sinus fistulae could
either be bilaterally fed from the carotid arteries or could
extend to the contralateral side via the intercavernous sinus,
making unilateral sinus packing often ineffective. Thus,
cavernous sinus dAVFs are the domain of endovascular
interventions [6]. In the rare cases in which the cavernous
sinus cannot be reached transvenously, surgery is indicated
to provide access to the cavernous sinus via the petrosal
vein [15], or the superior ophthalmic vein [49]f o r
retrograde catheterization. In one case, we disconnected
the arterialized leptomeningeal-draining vein and thereby
successfully increased the intracavernous pressure, which
“opened” the blocked petrous sinus for successful retro-
grade embolization, which is a strategy that has not been
reported so far. Very rarely, embolization proved to be not
possible, as witnessed in one patient, and microsurgical
sinus packing remains the only treatment option.
Limitations of the study
In many surgical and radiosurgical and some endovas-
cular series, angiographic follow-up investigations in
addition to early angiography after surgery were per-
formed only sporadically or within less than 4 months [5,
16, 18, 20, 22, 31, 42]. Our study shares this limitation.
From the scientific standpoint, repetitive follow-up angiog-
raphy would be of interest to prove sustained occlusion of
the fistula and to exclude distant fistula development. On
the other hand, surgical series and recent endovascular
series of transvenous embolization indicate that re-opening
of the fistula is very rare after complete occlusion, which
probably justifies that non-invasive imaging modalities
such as MRI and CT angiography or, very recently,
intravenous angiographic CT are used for follow-up
imaging [12, 36, 44, 47].
Other treatment options
In 2005, Koebbe et al. described 18 cases of dAVF
treatment either with gamma knife radiosurgery alone or
in combination with embolization [20]. They achieved a
total obliteration rate of 83.3%. Friedman et al described
their experiences with combined stereotactic radiosurgery
and transarterial embolization for dAVFs of the transverse
and sigmoid sinus. Although symptoms resolved or
improved in 96% of the patients, 59% of the lesions were
observed to persist to some degree on follow-up angio-
grams [11]. Apart of the comparatively low occlusion rate,
it has to be taken into account that it takes months to years
for thrombosis to occur, which is not acceptable if dealing
with dAVFs of the aggressive type. At least if dealing with
aggressive dAVFs, surgery and embolization remain the
mainstays of the therapeutic management.
Conclusion
Our surgical strategy was to focus on the arterialized
leptomeningeal vein in the non-sinus-type fistulae and on
the arterialized sinus segment in the sinus-type fistulae.
With this strategy, the operative morbidity is low and the
dAVF occlusion rate is high in both non-sinus and sinus-
type fistulas. In the light of these results, we propose that
microsurgery should be considered early in the manage-
ment of aggressive cranial dAVFs. The only exceptions are
selected cases of cavernous sinus dAVFs in which the role
of surgery is not the elimination of the fistula, but the
establishment of an access to the venous system for
retrograde embolization.
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Comments
Nicholas C. Bambakidis, Cleveland, USA
This paper reports on a large series of dural AVFs, all of which
were treated surgically. The authors point out accurately that no direct
comparison studies are available between surgical treatment and
endovascular management of these lesions. This is a nice review and
is timely. Advancing technology has made endovascular treatment of
such lesions increasingly possible. In particular, the “sinus-type” of
dAVFs are generally quite amenable to endovascular treatment, and
though the authors note a good success rate with open surgical
treatment, only 12 such cases are described. In fact, the endovascular
literature regarding transvenous embolization is quite impressive and,
in my opinion, surgical management of these lesions is rarely
necessary. This paper should not be taken to reflect the opinion that
dAVFs involving the sinus should be treated surgically as a primary
option, and in fact the authors note that the less invasive nature of
endovascular treatment favors it as the primary modality in the
majority of cases.
Additionally, the authors nicely review the literature for “non-sinus
type” dAVFs, which are primarily surgical lesions easily treated by
primary obliteration of the fistula by interrupting venous outflow.
William T. Couldwell, Steven Stevens, Salt Lake City, USA
The authors have reviewed the treatment and outcomes of 42
patients with dural arteriovenous fistulas (AVFs) at their institutions
over a 20-year period (1990–2010). They note that of the 42 patients,
12 had the sinus-type of fistula while 30 had the non-sinus type. The
majority (30 patients) had the higher Borden angiographic grade (II or
III) indicating increased risk of intracranial hemorrhage from
retrograde cortical venous drainage. In this regard, 40% of the patients
had suffered an intracerebral or subarachnoid hemorrhage prior to
treatment.
In the non-sinus type of fistulas, the technique of subarachnoid
vein interruption was used (clipped or coagulated). For the sinus-type
dAVFs, the technique employed was to pack the arterialized sinus with
oxidized cellulose (nine cases) to provide transvenous access to the
fistula for endovascular obliteration (three cases). At a mean follow-up
period of 42 months, there was no recanalization of fistula in those
that were initially obliterated; and, in the one patient with partial
treatment, there was no clinical or radiographic progression during
follow-up. The authors should be commended on their successful
treatment of this difficult group of patients.
The experience of the authors represents the best example of the
surgical ability to repair the dAVF. Admittedly, the authors have
imperfect follow-up as late angiography was not obtained in many
patients. Our recent experience with endovascular techniques indicates
that in the majority of patients, this would be our first option.
The authors note the recent introduction of Onyx, a liquid embolic
agent consisting of an EtOH copolymer suspended in DMSO and
using tantalum powder as a contrast agent, as an embolic agent for the
treatment of both direct and indirect arteriovenous fistulas. With
incremental experience with Onyx, new delivery techniques have
improved the distal penetration and safer control of the material. The
use of the “plug and push”, the dual catheters in separate territories,
the tandem dual catheters in a single feeder and the use of balloon
assist for direction control have all resulted in safer and improved rates
of complete AVF cure.
Although the number of reported cases treated with these newer
techniques is small, the success rates are rapidly improving. The
advantage of endovascular treatment is the immediate confirmation of
occlusion and the decreased length of hospital stay. The disadvantage
is the increased radiation exposure during prolonged injection. This
can be somewhat mitigated by the use of lower frame rates during the
injection process and the careful attention to radiation safety
principles.
Basant Misra, Mumbai, India
The authors report their experience with microsurgical treatment of
42 aggressive (Borden Types II and III) dural arteriovenous fistulas
(dAVFs) over a 20-year period. There were 30 non-sinus-type and 12
sinus-type fistulas. Microsurgical interruption of arterialized vein was
the sole treatment in the non-sinus-type fistula. Complete obliteration
of the dAVF was achieved in all but one case of this type. In the sinus
type, packing of the sinus was done with successful obliteration of the
dAVF in 9 out of 12. In the remaining three, the microsurgical strategy
was to provide access for retrograde catheterization and embolization.
Overall, the dAVF occlusion rate was a remarkable 97.6%. Permanent
neurological deficit attributable to surgery was found in only 7.1%
cases. The authors have to be congratulated for the excellent results
achieved in their series of dAVF treated microsurgically. The strategy
employed is simple and definitely economical compared to endovas-
cular treatment. However, one of the major limitations of this study is
lack of long-term follow-up angiographic data.
Endovascular treatment has been the first line of treatment in our
department for most aggressive dural AVF. We do occasionally resort
to microsurgery as the primary treatment for the non-sinus-type dAVF.
One of the problems, in our experience, is the presence of multiple
arterialized veins and difficulty in choosing the critical communication
to be interrupted. Our recent experience with ICG dye videoangiog-
raphy has been quite encouraging in defining and sacrificing the
retrograde arterialized draining vein.
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